BenzingaOctober 19, 2026 at 5:13 AM NY8 Days Ago
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $180
Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:RGEN) with a Hold and raises the price target from $145 to $180.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
